Pharma eyes AI deals to stem lost revenues from patent expirations
Pharmaceutical giants are employing an array of tactics to minimise the falling revenues that come when patents expire…
Pharmaceutical giants are employing an array of tactics to minimise the falling revenues that come when patents expire…